Rights and permissions
About this article
Cite this article
CYP2C9-based warfarin therapy better value than standard care. Pharmacoecon. Outcomes News 463, 10 (2004). https://doi.org/10.2165/00151234-200404630-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404630-00026